Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01991210
Title A Randomized Study of DNIB0600A in Comparison With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Genentech, Inc.
Indications

ovary epithelial cancer

peritoneum cancer

fallopian tube cancer

Therapies

DNIB0600A

Pegylated liposomal-doxorubicin

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.